Stock Price
1,184.10
Daily Change
-8.30 -0.70%
Monthly
-10.63%
Yearly
-14.49%
Q2 Forecast
1,166.41

Cipla reported INR807.77M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Arca Biopharma USD 48.72M 338K Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Bio Path USD 9.24M 934K Sep/2025
Brainstorm Cell Therapeutics USD 11.04M 2K Dec/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Immunic USD 8K 4K Jun/2024
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Minerva Neurosciences USD 1000 0 Sep/2024
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
TherapeuticsMD USD 11K 0 Sep/2023
UPL INR 843.31M 746.69M Sep/2025